News

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
Over the past three decades there have been amazing advances in treating and preventing HIV.It's now a manageable infection.
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Gilead Sciences, maker of the drug, announced that a twice-a-year injection of lenacapavir has been approved in the United States for HIV prevention under the brand name Yeztugo.
COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...
The administration’s proposed budget for HIV prevention represents a 78 percent reduction compared to last fiscal year.
Michigan public health leaders and research scientists say the fallout from Trump administration cuts to federal research ...
Despite fewer new diagnoses, the number of those living with HIV surpassed 1 million in 2018 and 1.1 million in 2023.